A METHOD OF SELECTING A MEDICATION FOR A PATIENT

    公开(公告)号:EP3703058A1

    公开(公告)日:2020-09-02

    申请号:EP20168461.0

    申请日:2006-11-28

    IPC分类号: G16B20/20 C12Q1/68

    摘要: A method of selecting a medication for a patient on the basis of an individualized medication report for the patient which comprises a group of possible medications drawn from a set of possible medications that includes at least one medication selected from propranolol, diazepam, alprazolam and risperidone based on the patient's phenotype and scored on the basis of the patient's genotype as determined by a genotyping assay for CYP genes consisting of 1A2, 2B6, 2C9, 2C19, 2D6 and 3A4 using a biological sample obtained from the patient.

    OPTIMIZATION AND INDIVIDUALIZATION OF MEDICATION SELECTION AND DOSING
    2.
    发明公开
    OPTIMIZATION AND INDIVIDUALIZATION OF MEDICATION SELECTION AND DOSING 审中-公开
    药物选择和剂量的优化和个体化

    公开(公告)号:EP3223182A1

    公开(公告)日:2017-09-27

    申请号:EP17154177.4

    申请日:2006-11-28

    IPC分类号: G06F19/00 C12Q1/68

    摘要: The invention provides population models, methods, and algorithms for targeting a dosing regimen or compound selection to an individual patient. The methods and algorithms of the invention utilize population models that incorporate genotype information for genes encoding drug metabolizing enzymes for one or more compounds of interest. The methods allow integration of genotype information for one or more genes encoding a drug metabolizing enzyme, particularly a cytochrome P450 gene with patient data. The methods allow integration of genotype information and the effect of one or more compounds on one or more drug metabolizing enzymes. The methods allow iterative feedback of drug metabolizing data obtained from a patient into the process of generating a dosage regimen recommendation for a compound of interest for an individual patient.

    摘要翻译: 本发明提供了用于将给药方案或化合物选择靶向至个体患者的群体模型,方法和算法。 本发明的方法和算法利用整合编码一种或多种感兴趣化合物的药物代谢酶的基因的基因型信息的群体模型。 该方法允许将编码药物代谢酶,特别是细胞色素P450基因的一种或多种基因的基因型信息与患者数据整合。 该方法允许整合基因型信息和一种或多种化合物对一种或多种药物代谢酶的作用。 该方法允许从患者获得的药物代谢数据的迭代反馈进入为个体患者产生感兴趣化合物的剂量方案推荐的过程。